Log in
Enquire now
‌

US Patent 11324753 Method of treatment of attention deficit/hyperactivity disorder (ADHD)

Patent 11324753 was granted and assigned to Supernus Pharmaceuticals, Inc. on May, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11324753 Method of treatment of attention deficit/hyperactivity disorder (ADHD)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo